These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 31578585)

  • 1. Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin‑mediated mitophagy.
    Li Z; Wang Y; Wu L; Dong Y; Zhang J; Chen F; Xie W; Huang J; Lu N
    Oncol Rep; 2019 Dec; 42(6):2245-2254. PubMed ID: 31578585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics reveals a therapeutic vulnerability via the combined blockade of APE1 and autophagy in lung cancer A549 cells.
    Pan ST; Zhou J; Yang F; Zhou SF; Ren T
    BMC Cancer; 2020 Jul; 20(1):634. PubMed ID: 32641008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APE1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and targeted inhibition of APE1 enhances the activity of cisplatin in A549 cells.
    Wang D; Xiang DB; Yang XQ; Chen LS; Li MX; Zhong ZY; Zhang YS
    Lung Cancer; 2009 Dec; 66(3):298-304. PubMed ID: 19324449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin-1 knockdown increases the therapeutic sensitivity of lung cancer to cisplatin-induced apoptosis by repressing Parkin-related mitophagy and activating the ROCK1 pathway.
    Liu Y; Fu Y; Hu X; Chen S; Miao J; Wang Y; Zhou Y; Zhang Y
    J Cell Physiol; 2020 Feb; 235(2):1197-1208. PubMed ID: 31270811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of TRIM65 inhibits autophagy and cisplatin resistance in A549/DDP cells by regulating miR-138-5p/ATG7.
    Pan X; Chen Y; Shen Y; Tantai J
    Cell Death Dis; 2019 Jun; 10(6):429. PubMed ID: 31160576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial APE1 promotes cisplatin resistance by downregulating ROS in osteosarcoma.
    Liu Y; Zhang Z; Li Q; Zhang L; Cheng Y; Zhong Z
    Oncol Rep; 2020 Aug; 44(2):499-508. PubMed ID: 32627008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX2 knockdown with siRNA reverses cisplatin resistance in NSCLC by regulating APE1 signaling.
    Chen TY; Zhou J; Li PC; Tang CH; Xu K; Li T; Ren T
    Med Oncol; 2022 Jan; 39(3):36. PubMed ID: 35059870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin.
    Gong X; Liu J; Zhang D; Yang D; Min Z; Wen X; Wang G; Li H; Song Y; Bai C; Li J; Zhou J
    PLoS One; 2017; 12(8):e0182410. PubMed ID: 28771580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential treatment with AT-101 enhances cisplatin chemosensitivity in human non-small cell lung cancer cells through inhibition of apurinic/apyrimidinic endonuclease 1-activated IL-6/STAT3 signaling pathway.
    Ren T; Shan J; Qing Y; Qian C; Li Q; Lu G; Li M; Li C; Peng Y; Luo H; Zhang S; Zhang W; Wang D; Zhou SF
    Drug Des Devel Ther; 2014; 8():2517-29. PubMed ID: 25548514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced apurinic/apyrimidinic endonuclease activity enhances the antitumor activity of oxymatrine in lung cancer cells.
    Wang Z; Xu W; Lin Z; Li C; Wang Y; Yang L; Liu G
    Int J Oncol; 2016 Dec; 49(6):2331-2340. PubMed ID: 27748797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-elemene reverses the drug resistance of lung cancer A549/DDP cells via the mitochondrial apoptosis pathway.
    Yao CC; Tu YR; Jiang J; Ye SF; Du HX; Zhang Y
    Oncol Rep; 2014 May; 31(5):2131-8. PubMed ID: 24627125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyubiquitination of apurinic/apyrimidinic endonuclease 1 by Parkin.
    Scott TL; Wicker CA; Suganya R; Dhar B; Pittman T; Horbinski C; Izumi T
    Mol Carcinog; 2017 Feb; 56(2):325-336. PubMed ID: 27148961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling of apoptosis- and autophagy-associated molecules in human lung cancer A549 cells in response to cisplatin treatment using stable isotope labeling with amino acids in cell culture.
    Wang Z; Liu G; Jiang J
    Int J Oncol; 2019 Mar; 54(3):1071-1085. PubMed ID: 30664195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytoplasmic APE1 promotes resistance response in osteosarcoma patients with cisplatin treatment.
    Liu Y; Zhang Z; Zhang L; Zhong Z
    Cell Biochem Funct; 2020 Mar; 38(2):195-203. PubMed ID: 31930546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of VBMDMP on the reversal of cisplatin resistance in human lung cancer A549/DDP cells.
    Wang CK; Zhang Y; Zhang ZJ; Qiu QW; Cao JG; He ZM
    Oncol Rep; 2015 Jan; 33(1):372-82. PubMed ID: 25394854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer.
    Ren T; Shan J; Li M; Qing Y; Qian C; Wang G; Li Q; Lu G; Li C; Peng Y; Luo H; Zhang S; Yang Y; Cheng Y; Wang D; Zhou SF
    Drug Des Devel Ther; 2015; 9():2887-910. PubMed ID: 26089640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human apurinic/apyrimidinic endonuclease siRNA inhibits the angiogenesis induced by X-ray irradiation in lung cancer cells.
    Gu X; Cun Y; Li M; Qing Y; Jin F; Zhong Z; Dai N; Qian C; Sui J; Wang D
    Int J Med Sci; 2013; 10(7):870-82. PubMed ID: 23781133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN-mediated mitophagy and APE1 overexpression protects against cardiac hypoxia/reoxygenation injury.
    Tang W; Lin D; Chen M; Li Z; Zhang W; Hu W; Li F
    In Vitro Cell Dev Biol Anim; 2019 Oct; 55(9):741-748. PubMed ID: 31432320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APE1 modulates cellular responses to organophosphate pesticide-induced oxidative damage in non-small cell lung carcinoma A549 cells.
    Thakur S; Dhiman M; Mantha AK
    Mol Cell Biochem; 2018 Apr; 441(1-2):201-216. PubMed ID: 28887667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells.
    Li Y; Hu T; Chen T; Yang T; Ren H; Chen M
    Oncol Rep; 2018 Feb; 39(2):565-572. PubMed ID: 29207165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.